Literature DB >> 19745759

The epidemiology and clinical characteristics of patients with newly diagnosed alcohol-related liver disease: results from population-based surveillance.

Andre N Sofair1, Vaughn Barry, M Michele Manos, Ann Thomas, Atif Zaman, Norah A Terrault, Rosemary C Murphy, Nicole Stabach, Sharon Huie, Grace Van Ness, Beth P Bell, Stephanie Bialek.   

Abstract

GOALS: We describe the epidemiology of outpatients newly diagnosed with chronic alcoholic liver disease and describe predictors of cirrhosis and referral for specialty care.
BACKGROUND: Alcohol is a major cause of liver disease in the United States. Most previous work has described hospitalized patients. STUDY: Participants were identified through prospective population-based surveillance in gastroenterology practices Multnomah County, Oregon and New Haven County, Connecticut; and primary care and gastroenterology practices from Kaiser Permanente Northern California in Alameda County during 1999 to 2001. Patients were interviewed, a blood specimen obtained, and their medical record reviewed.
RESULTS: We identified 82 patients from gastroenterology practices with newly diagnosed alcoholic liver disease. Their median age was 50.0 years. 72.0% were male and 79.3% were White. The median age at initiation of alcohol use was 17.0 years. 43.9% of patients had evidence of cirrhosis at the time of diagnosis. Only 40.2% reported alcohol as the cause of their liver disease. Patients with cirrhosis were more likely to be older, have a higher median number of years of heavy alcohol consumption, and to have been hospitalized for a liver-related complication than noncirrhotic patients. An additional 83 primary care patients were more likely to be older, to be drinking alcohol at study interview, and to not have cirrhosis than patients referred for gastroenterology care.
CONCLUSIONS: Patients with alcoholic liver disease may present at a late stage and may not identify alcohol as a cause for their liver disease. Improved patient screening and education may limit morbidity and mortality.

Entities:  

Mesh:

Year:  2010        PMID: 19745759     DOI: 10.1097/MCG.0b013e3181b3f760

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  15 in total

1.  Improved Survival Among all Interferon-α-Treated Patients in HCV-002, a Veterans Affairs Hepatitis C Cohort of 2211 Patients, Despite Increased Cirrhosis Among Nonresponders.

Authors:  Myrna L Cozen; James C Ryan; Hui Shen; Ramsey Cheung; David E Kaplan; Christine Pocha; Norbert Brau; Ayse Aytaman; Warren N Schmidt; Marcos Pedrosa; Bhupinderjit S Anand; Kyong-Mi Chang; Timothy Morgan; Alexander Monto
Journal:  Dig Dis Sci       Date:  2016-04-08       Impact factor: 3.199

Review 2.  Optimal management for alcoholic liver disease: Conventional medications, natural therapy or combination?

Authors:  Moon-Sun Kim; Madeleine Ong; Xianqin Qu
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

Review 3.  Outpatient management of alcohol-related liver disease.

Authors:  Douglas A Simonetto; Vijay H Shah; Patrick S Kamath
Journal:  Lancet Gastroenterol Hepatol       Date:  2020-05

4.  Treatment of alcoholic liver disease.

Authors:  Thomas H Frazier; Abigail M Stocker; Nicole A Kershner; Luis S Marsano; Craig J McClain
Journal:  Therap Adv Gastroenterol       Date:  2011-01       Impact factor: 4.409

5.  Estimating alcohol-attributable liver disease mortality: A comparison of methods.

Authors:  Adam Sherk; Marissa B Esser; Tim Stockwell; Timothy S Naimi
Journal:  Drug Alcohol Rev       Date:  2022-04-01

Review 6.  The etiology, diagnosis and prevention of liver cirrhosis: part 1 of a series on liver cirrhosis.

Authors:  Johannes Wiegand; Thomas Berg
Journal:  Dtsch Arztebl Int       Date:  2013-02-08       Impact factor: 5.594

Review 7.  Rodent models of alcoholic liver disease: of mice and men.

Authors:  Elizabeth Brandon-Warner; Laura W Schrum; C Max Schmidt; Iain H McKillop
Journal:  Alcohol       Date:  2012-09-07       Impact factor: 2.405

8.  Age and ethnicity in cirrhosis.

Authors:  Krishna C Sajja; Desh P Mohan; Don C Rockey
Journal:  J Investig Med       Date:  2014-10       Impact factor: 2.895

9.  Establishment of the tree shrew as an alcohol-induced Fatty liver model for the study of alcoholic liver diseases.

Authors:  Huijie Xing; Kun Jia; Jun He; Changzheng Shi; Meixia Fang; Linliang Song; Pu Zhang; Yue Zhao; Jiangnan Fu; Shoujun Li
Journal:  PLoS One       Date:  2015-06-01       Impact factor: 3.240

10.  Nonresponse to interferon-α based treatment for chronic hepatitis C infection is associated with increased hazard of cirrhosis.

Authors:  Myrna L Cozen; James C Ryan; Hui Shen; Robert Lerrigo; Russell M Yee; Edward Sheen; Richard Wu; Alexander Monto
Journal:  PLoS One       Date:  2013-04-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.